Cancer Causes & Control

, Volume 23, Issue 2, pp 281–288

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions

  • Susan Hariri
  • Elizabeth R. Unger
  • Suzanne E. Powell
  • Heidi M. Bauer
  • Nancy M. Bennett
  • Karen C. Bloch
  • Linda M. Niccolai
  • Sean Schafer
  • Lauri E. Markowitz
  • The HPV-IMPACT Working Group
Original paper

DOI: 10.1007/s10552-011-9877-6

Cite this article as:
Hariri, S., Unger, E.R., Powell, S.E. et al. Cancer Causes Control (2012) 23: 281. doi:10.1007/s10552-011-9877-6

Abstract

The following paper describes a collaboration between the Centers for Disease Control and Prevention and five Emerging Infections Program sites to develop a comprehensive population-based approach to monitoring human papillomavirus (HPV) vaccine impact on cervical cancer precursors and associated HPV genotypes. The process of establishing this novel monitoring system is described, and development details such as enumeration of sources for reporting cervical intraepithelial neoplasia 2/3 and adenocarcinoma in situ, approaches to case ascertainment, electronic reporting, and HPV typing are outlined. Implementation of a feasible and sustainable surveillance system for HPV-associated cervical precancers will enable evaluation of the direct impact of HPV vaccination.

Keywords

Human Papillomavirus (HPV)Cervical intraepithelial neoplasia (CIN)Cervical adenocarcinoma in situ (AIS)Post-licensure vaccine effectivenessVaccine impactSurveillance

Copyright information

© Springer Science+Business Media B.V. (outside the USA)  2011

Authors and Affiliations

  • Susan Hariri
    • 1
  • Elizabeth R. Unger
    • 3
  • Suzanne E. Powell
    • 2
  • Heidi M. Bauer
    • 4
  • Nancy M. Bennett
    • 5
  • Karen C. Bloch
    • 6
  • Linda M. Niccolai
    • 7
  • Sean Schafer
    • 8
  • Lauri E. Markowitz
    • 2
  • The HPV-IMPACT Working Group
  1. 1.Division of STD PreventionNational Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and PreventionAtlantaUSA
  2. 2.Division of STD PreventionNational Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and PreventionAtlantaUSA
  3. 3.Division of High-Consequence Pathogens and PathologyNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and PreventionAtlantaUSA
  4. 4.STD Control Branch, California Department of HealthRichmondUSA
  5. 5.Center for Community Health and Department of MedicineUniversity of Rochester School of Medicine and DentistryRochesterUSA
  6. 6.Departments of Medicine and Preventive MedicineVanderbilt University Medical CenterNashvilleUSA
  7. 7.Division of Epidemiology of Microbial DiseasesYale School of Public HealthNew HavenUSA
  8. 8.HIV/STD/TB Program, Division of STD, Oregon Department of Human ServicesPortlandUSA